Skip to content

Neopharma Technologies Ltd blog

A brief introductory description of your blog and the topics covered at a high level. Just one or two sentences should be just right.

Neopharma Technologies and Impairment Science Strengthen Partnership to Revolutionize Drug and Impairment Testing

Neopharma Technologies and Impairment Science Strengthen Partnership to Revolutionize Drug and Impairment Testing

Neopharma Technologies Announces Strategic Partnership with AusChain to Assist with the Scaling and Global Rollout of NEOVAULT®

Neopharma Technologies Appoints Exchange Listing to Manage U.S. IPO

Neopharma Technologies and Orient Gene Partner to Digitize Healgen® Drug Test Portfolio Globally with NEOVAULT®

Neopharma Technologies Appoints Singapore Fintech Veteran and Serial Entrepreneur Mr. Joo Seng Wong as Board Advisor to Oversee Institutional Strategy and Global Execution

Neopharma Technologies Ltd Announces Full Integration of NEOVAULT® with DRUID®

ADDRESSING ADDICTION THROUGH THE GREAT AMERICAN RECOVERY INITIATIVE

HSI Donesafe and Neopharma Technologies Announce API Integration for Fit-For-Duty Workflows

As Marijuana Use Grows, Effect on Road Safety Remains a Blind Spot

Previous page 1 2 Next page

Neopharma Technologies
Australia: 1800 636 8378 – US/Canada : 1844 636 8378
PERTH, AUSTRALIA - KUALA LUMPUR, MALAYSIA - PHILADELPHIA, USA